Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
11.2 USD | +0.81% | +24.45% | +106.66% |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
Jul. 11 | Ars Pharmaceuticals Insider Sold Shares Worth $961,725, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+106.66% | 1.08B | |
+27.39% | 47.07B | |
+46.45% | 42.06B | |
-4.32% | 39.98B | |
+37.15% | 33.02B | |
-7.79% | 27.9B | |
+19.03% | 27.63B | |
+49.45% | 14.37B | |
+41.98% | 13.45B | |
+0.34% | 12.03B |
- Stock Market
- Equities
- SPRY Stock
- News ARS Pharmaceuticals, Inc.
- Silverback Therapeutics, Inc. Appoints Andrew Powell as Director